|
WO2007062363A2
|
|
Method for diagnosing a person having sjogren's syndrome
|
|
EP1934335A2
|
|
Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
|
|
AU2006203434A1
|
|
A process for isolating and purifying viruses, soluble proteins and peptides from plant sources
|
|
US2006281075A1
|
|
Purification of viruses, proteins and nucleic acids
|
|
WO2006042327A2
|
|
Plant-produced recombinant aprotinin and aprotinin variants
|
|
US2006024272A1
|
|
C-terminally truncated interferon
|
|
US2005227278A1
|
|
Recursive categorical sequence assembly
|
|
US2006029612A1
|
|
Prevention and treatment of recurrent respiratory papillomatosis
|
|
ZA200502987B
|
|
Polyucleotide sequence variants
|
|
US2005282263A1
|
|
Flexible vaccine assembly and vaccine delivery platform
|
|
WO2005091753A2
|
|
Flexible vaccine assembly and vaccine delivery platform
|
|
US2005210543A1
|
|
Nucleic acid molecules encoding cel I endonuclease and methods of use thereof
|
|
ZA200501807B
|
|
Production of peptides in plants as viral coat protein fusions
|
|
US2006039895A1
|
|
Ex-vivo rescue of hematopoietic stem cells after lethal irradiation
|
|
US2005005319A1
|
|
Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
|
|
US2004259221A1
|
|
Separation of cytosolic and nuclear proteins
|
|
AU2003284904A1
|
|
Polynucleotide sequence variants
|
|
US2004064855A1
|
|
Production of lysosomal enzymes in plants by transient expression
|
|
AU2003282667A1
|
|
Multimeric protein engineering
|
|
US2004053225A1
|
|
Enhancement of virus induced gene silencing (VIGS) through viral-based expression of inverted-repeats
|
